Following on from information provided to NICE by the company in June 2017, the appraisal of Heart failure (oedema) - furosemide micro-pump was suspended from NICE’s work programme. As no further information has been received from the company the topic has been discontinued.
| Status | Discontinued |
| Technology type | Medicine |
| Decision | Selected |
| Process | TA |
| ID number | 1061 |
Email enquiries
- If you have any queries please email scheduling@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 16 November 2022 | Discontinued. Following on from information provided to NICE by the company in June 2017, the appraisal of Heart failure (oedema) - furosemide micro-pump was suspended from NICE’s work programme. As no further information has been received from the company the topic has been discontinued. |
| 03 July 2017 | Following on from advice received from the company, the dates for this appraisal will be confirmed once regulatory approval timelines are established. |
| 21 April 2017 | Referral |
| 21 April 2017 | In progress. Topic referred |
| 18 November 2016 - 16 December 2016 | Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators |
For further information on our processes and methods, please see our CHTE processes and methods manual